Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Inhibition of Rhabdomyosarcoma’s Bone Marrow Metastasis through Blocking of MET Receptor Signaling.

Ewa Lesko, M.Sci., Katarzyna Miekus, Ph.D., Jacek Kijowski, Ph.D., M.D, Grazyna Drabik, M.D., Miroslawa Wilusz, M.D., Marcin Majka, PhD

Blood (2007) 110 (11): 1926.

https://doi.org/10.1182/blood.V110.11.1926.1926

Published: 2007

Journal Articles

Increased Expression of Pro-Angiogenic and Decreased Expression of Osteogenic Genes by Multipotential Stromal Cells after Stimulation with Myeloma-Derived Microvesicles.

Anna Zebzda, M.Sci., Artur Jurczyszyn, M.D., Ph.D., Danuta Jarocha, M.Sci., Aleksander B. Skotnicki, M.D., Ph.D., Marcin Majka, PhD

Blood (2007) 110 (11): 3515.

https://doi.org/10.1182/blood.V110.11.3515.3515

Published: 2007

Journal Articles

Hematopoietic Allotransplant Studies in Complement Deficient Mice Reveal Beneficial Role of Innate Immunity in Ameliorating Consequences of GVHD.

Oktawiusz Wiecha, MD, Witold Miezynski, MD, Leszek Wojakiewicz, MSci, Anna Zebzda, MSci, Anna Wendrychowicz, MD,PhD, Jolanta Gozdzik, MD,PhD, Mariusz Z. Ratajczak, MD,PhD, Marcin Majka, PhD

Blood (2006) 108 (11): 5165.

https://doi.org/10.1182/blood.V108.11.5165.5165

Published: 2006

Journal Articles

New GvHD Mouse Model for Assessing Both Acute and Chronic Phase of the Disease.

Oktawiusz Wiecha, MD, Witold Miezynski, MD, Leszek Wojakiewicz, MSci, Anna Zebzda, MSci, Anna Wedrychowicz, MD,PhD, Jolanta Gozdzik, MD,PhD, Marcin Majka, PhD

Blood (2006) 108 (11): 5166.

https://doi.org/10.1182/blood.V108.11.5166.5166

Published: 2006

Journal Articles

Comparison of Different Strategies of MSC Isolation Revels Advantage To Expand MSC Directly from Purified CD105 + and CD271 + Cells.

Danuta Jarocha, MSci, Ewa Lesko, MSci, Mariusz Z. Ratajczak, MD, PhD, Marcin Majka, PhD

Blood (2006) 108 (11): 2566.

https://doi.org/10.1182/blood.V108.11.2566.2566

Published: 2006

Journal Articles

Different Sensitivity of Normal and Malignant Cells to HSP90 Inhibitors.

Ewa Lesko, MSci, Anna Zebzda, MSci, Danuta Jarocha, Msci, Marcin Majka, PhD

Blood (2006) 108 (11): 4377.

https://doi.org/10.1182/blood.V108.11.4377.4377

Published: 2006

Journal Articles

Comparison of Myeloma Cells Killing Efficiency by Geldanamycin and Its Analogs.

Anna Zebzda, MSci, Artur Jurczyszyn, MD,PhD, Wojciech Czogala, MD, Ewa Lesko, MSci, Jolanta Gozdzik, MD,PhD, Aleksander B. Skotnicki, MD,PhD, Marcin Majka, PhD

Blood (2006) 108 (11): 5027.

https://doi.org/10.1182/blood.V108.11.5027.5027

Published: 2006

Journal Articles

C-met Receptor as a Potential Target for the Treatment of Patients with Multiple Myeloma.

Marcin Majka, PhD, Artur Jurczyszyn, MD, PhD, Anna Zebzda, MSci, Wojciech Czogala, MD, Ewa Lesko, MSci, Zbigniew Rudzki, MD, PhD, Jolanta Gozdzik, MD, PhD, Teresa Wolska-Smolen, MD, PhD, Aleksander B. Skotnicki, MD, PhD, Mariusz Z. Ratajczak, MD, PhD

Blood (2005) 106 (11): 3395.

https://doi.org/10.1182/blood.V106.11.3395.3395

Published: 2005

Journal Articles

Evidence That Functional Neural Tissue-Committed Stem Cells (NTCSC) Reside in the Human Bone Marrow and Are Mobilized into Peripheral Blood in a Patients after Stroke.

Magda Kucia, PhD, Edyta Paczkowska, MD, PhD, Marcin Majka, PhD, Bogdan Machalinski, MD, PhD, Mariusz Z. Ratajczak, MD, PhD

Blood (2005) 106 (11): 392.

https://doi.org/10.1182/blood.V106.11.392.392

Published: 2005

Journal Articles

Unexpected Evidence That Dimethylsulphoxide (DMSO) Upregulates Expression of CXCR4 on Hematopoietic Stem/Progenitor Cells (HSPC), Increases Their Responsiveness to an SDF-1 Gradient and Enhances Homing to Bone Marrow.

Marcin Majka, PhD, Danuta Jarocha, MSci, Marcin Wysoczynski, MSci, Duygu Sag, Ewa Zuba-Surma, PhD, Jacek Kijowski, MD, PhD, Jolanta Gozdzik, MD, PhD, Mariusz Z. Ratajczak, MD, PhD

Blood (2005) 106 (11): 1973.

https://doi.org/10.1182/blood.V106.11.1973.1973

Published: 2005

Journal Articles

CXCR4 + CD45 − Tissue-Committed Stem Cells (TCSC) for Myocardium Reside in the Bone Marrow, Are Mobilized into the Peripheral Blood during Myocardial Infarction, and “Home” to Infarcted Myocardium in CXCR4-SDF-1 and HGF/SF-c-Met Dependent Manner.

Magda Kucia, PhD, Buddhadeb Dawn, MD, Yiru Guo, MD, Greg Hunt, Marcin Wysoczynski, Marcin Majka, PhD, Ewa Zuba, PhD, Francine Rezzoug, PhD, Suzanne T. Ildstad, MD, Roberto Bolli, MD, PhD, Mariusz Z. Ratajczak, MD, PhD

Blood (2004) 104 (11): 2131.

https://doi.org/10.1182/blood.V104.11.2131.2131

Published: 2004

Journal Articles

More Evidence That the Phenomenon of “Plasticity” of Hematopoietic Stem Cells (HSC) and Potential Involvement of BM-Derived Cells in Organ Regeneration Could Be Explained by the Presence of a Heterogenous Population of Tissue Committed Stem Cells (TCSC) Residing/Hiding out in Bone Marrow.

Magda Kucia, PhD, Marcin Wysoczynski, Ryan Reca, Marcin Majka, PhD, Janina Ratajczak, MD, PhD, Mariusz Z. Ratajczak, MD, PhD

Blood (2004) 104 (11): 4173.

https://doi.org/10.1182/blood.V104.11.4173.4173

Published: 2004

NARROW

Inhibition of Rhabdomyosarcoma’s Bone Marrow Metastasis through Blocking of MET Receptor Signaling.

Increased Expression of Pro-Angiogenic and Decreased Expression of Osteogenic Genes by Multipotential Stromal Cells after Stimulation with Myeloma-Derived Microvesicles.

Hematopoietic Allotransplant Studies in Complement Deficient Mice Reveal Beneficial Role of Innate Immunity in Ameliorating Consequences of GVHD.

New GvHD Mouse Model for Assessing Both Acute and Chronic Phase of the Disease.

Comparison of Different Strategies of MSC Isolation Revels Advantage To Expand MSC Directly from Purified CD105 + and CD271 + Cells.

Different Sensitivity of Normal and Malignant Cells to HSP90 Inhibitors.

Comparison of Myeloma Cells Killing Efficiency by Geldanamycin and Its Analogs.

C-met Receptor as a Potential Target for the Treatment of Patients with Multiple Myeloma.

Evidence That Functional Neural Tissue-Committed Stem Cells (NTCSC) Reside in the Human Bone Marrow and Are Mobilized into Peripheral Blood in a Patients after Stroke.

Unexpected Evidence That Dimethylsulphoxide (DMSO) Upregulates Expression of CXCR4 on Hematopoietic Stem/Progenitor Cells (HSPC), Increases Their Responsiveness to an SDF-1 Gradient and Enhances Homing to Bone Marrow.

CXCR4 + CD45 − Tissue-Committed Stem Cells (TCSC) for Myocardium Reside in the Bone Marrow, Are Mobilized into the Peripheral Blood during Myocardial Infarction, and “Home” to Infarcted Myocardium in CXCR4-SDF-1 and HGF/SF-c-Met Dependent Manner.

More Evidence That the Phenomenon of “Plasticity” of Hematopoietic Stem Cells (HSC) and Potential Involvement of BM-Derived Cells in Organ Regeneration Could Be Explained by the Presence of a Heterogenous Population of Tissue Committed Stem Cells (TCSC) Residing/Hiding out in Bone Marrow.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only